Catherine Novack
Stock Analyst at Jones Trading
(0.39)
# 4,082
Out of 4,888 analysts
20
Total ratings
17.65%
Success rate
-21.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DYN Dyne Therapeutics | Initiates: Buy | $30 | $8.39 | +257.57% | 1 | Jun 26, 2025 | |
CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $10.17 | +185.15% | 2 | Jun 25, 2025 | |
FEMY Femasys | Maintains: Buy | $10 → $6 | $0.92 | +552.17% | 2 | May 13, 2025 | |
RLYB Rallybio | Downgrades: Hold | n/a | $0.51 | - | 1 | Apr 15, 2025 | |
PVLA Palvella Therapeutics | Initiates: Buy | $45 | $24.82 | +81.34% | 1 | Mar 25, 2025 | |
PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.20 | +400.00% | 1 | Feb 12, 2025 | |
KRRO Korro Bio | Initiates: Buy | $130 | $13.60 | +855.88% | 1 | Nov 18, 2024 | |
EQ Equillium | Downgrades: Hold | n/a | $0.31 | - | 1 | Nov 1, 2024 | |
WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.95 | +130.38% | 2 | Sep 25, 2024 | |
LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.32 | +321.69% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.40 | +441.67% | 2 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.97 | +101.21% | 1 | Apr 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.60 | +1,275.00% | 1 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.55 | - | 2 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.41 | +6,527.45% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $8.39
Upside: +257.57%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $10.17
Upside: +185.15%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.92
Upside: +552.17%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.51
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $24.82
Upside: +81.34%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $13.60
Upside: +855.88%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.95
Upside: +130.38%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.32
Upside: +321.69%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.40
Upside: +441.67%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.97
Upside: +101.21%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.60
Upside: +1,275.00%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.55
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.41
Upside: +6,527.45%